AstraZeneca exec bullish on China’s pharma industry
China’s clear message to support the development of innovative drugs has buoyed the spirits of foreign pharmaceutical companies and reinforced their commitments to align their global R&D capabilities with China’s robust pharmaceutical ecosystem, said a senior executive. “We’ve received strong signal from the policymakers that they are keen to foster innovation in the pharmaceutical industry.…









